The first component of complement, Cl, was isolated unactivated from human serum by repeated additions of di-isopropyl phosphorofluoridate during isolation. The unactivated subcomponents were also isolated, and evidence is given that the three subcomponents Clq, Clr and Cls account wholly for the activity of component Cl in serum. No evidence could be found for a fourth subcomponent, Clt. The approximate molar proportions of the subcomponents in serum are Clq/Clr/Cls = 1:2:2. Optimum activity by haemolytic assay was found at approximate molar proportions Clq/Clr/Cls of 1:4:4. No activity was found when subcomponents were assayed singly or in pairs, except for subcomponents Clq and Cls, which in molar ratio 1:4 gave 15-20% of the activity of the mixture Clq+ Clr+Cls. The proteolytic activity of the isolated subcomponent CTs varied according to the method of activation used. Subcomponents Clq+Clr+Cls and Clq+Cls in the presence of antibody-antigen aggregates were activated and inactivated simultaneously, showing a peak ofactivity and subsequent loss ofactivity. Both reactions are probably due to proteolysis, and analysis of the peptide bonds split will be necessary to distinguish these two phenomena.
the method of activation used. Subcomponents Clq+Clr+Cls and Clq+Cls in the presence of antibody-antigen aggregates were activated and inactivated simultaneously, showing a peak ofactivity and subsequent loss ofactivity. Both reactions are probably due to proteolysis, and analysis of the peptide bonds split will be necessary to distinguish these two phenomena.
Complement is a complex mixture of blood proteins which are activated sequentially, many by conversion of a proteolytic zymogen into an active proteinase, and which play an important role in the host defence against infection. There are two distinct ways of initiating activation of these proteins (Muiller-Eberhard, 1975 ). The first, or classical pathway, is activated by the interaction with aggregates of IgGt or IgM. A second, the alternative pathway, can be activated by naturally occurring polysaccharides and by antibody-antigen interaction, but in this case activation involves a different mechanism from that used in the initiation of the classical pathway (Reid & Porter, 1975) . In both cases activation leads to conversion of the third component (C3) into an active form and subsequent utilization of the late components, C5-C9. In the classical pathway the first component (CI) is converted by antibodyantigen aggregates from Cl into the active form CT (Lepow et al., 1956) . Component CT cleaves components C4 and C2 to give a complex proteolytic enzyme, C42, which converts component C3 into t Abbreviations: IgG, immunoglobulin G; IgM, immunoglobulin M (macroglobulin) (World Health Organisation, 1964) ; Dip-F, di-isopropyl phosphorofluoridate. The nomenclature of the components of complement is that recommended by World Health Organisation (1968) . Activation of a component is indicated by a bar.
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C3b and C3a (MOiller-Eberhard et al., 1967) . Component C3b continues in the pathway now common to both the classical and alternative pathways. Knowledge of the molecular mechanisms involved is increasing, but many steps are still unclear. In particular, study of the initiation of the activation of component Cl by antibody-antigen aggregates has been held up by the difficulty of isolating component Cl, as it is easily converted into the CT form during fractionation, probably owing to non-specific activation by traces of proteolytic enzymes in the serum. This has been overcome by repeated addition of the serine esterase inhibitor Dip-F and by working at pH5.5. The isolation ofcomponent Cl is described in this paper together with studies of the activation of the three subcomponent proteins Clq, Clr and Cls. (Fisons Scientific Reagents, Loughborough, Leics., U.K.) was recrystallized from ethanol.
Preparation ofcomponent Cl Serum (500ml) was thawed, 1 ml of 2.5 M-Dip-F in propan-2-ol added and then centrifuged at 12500g for 30min at 2°C to remove any sediment. The supernatant was added to 2 litres ofwater at 2°C containing 5mM-CaCI2, 2.5 mM-iodoacetamide and 0.2mM-phenanthroline, together with 0.5ml of 2.5mM-Dip-F; 1-2ml of 1 M-NaOH was added to re-adjust the pH to 7.4. The suspension was stirred in the coldroom for 2h and centrifuged at 12500g for 30min. The small precipitate of euglobulin was resuspended in 30ml of 0.04M-sodium acetate buffer (pH5.5)/ 5mM-CaCI2, 0.1 ml of 2.5 M-Dip-F was added and the mixture centrifuged. The precipitate was taken up in 15ml of 0.2M-NaCI/0.05M-sodium acetate buffer (pH5.5)/0mM-CaC2, and 0.05nml of 2.5M-Dip-F added. This solution was centrifuged for 30min at 75000g, the film of fat and the sediment were discarded and the slightly opalescent supernatant was fractionated on a column (90cm x Scm) of Sepharose 6B in the same buffer without Dip-F (Fig. 1) . The haemolytically active fractions were pooled as shown and concentrated to 15 ml by ultrafiltration after the addition of0.1 ml of2.5M-Dip-F. The Cl preparations were stable and remained unactivated at 2°C over several weeks, though some precipitation occurred.
Separation of subcomponents Clq, Clr and Cls after the addition of EDTA to 10mM was by gradient elution on a column (30cm x 1.2cm) of DEAEcellulose (Whatman DE32) with a starting buffer containing lOmM-NaH2PO4, 47mM-Na2HPO4, 5mM-EDTA, pH7.4 (500ml), and a final buffer of the same composition (500ml), but containing 0.5M-NaCl (Lepow et al., 1963) . Subcomponent Clr was purified further by chromatography on a column (90cm x 2.5cm) of Sephadex G-200 in 0.05M-sodium acetate buffer (pH 5.5)/0.1 M-NaCI/1 mM-EDTA. This purification step removed the contaminant associated with the whole component Cl, which was eluted from the DE32 cellulose column close to subcomponent Clr. Dip-F (2.5M) was added to the solutions of subcomponents Clq, Clr and Cls both before and after concentration to give approx. 5mM. All the subcomponents appeared to be pure as judged by electrophoresis in polyacrylamide gel in buffers containing sodium dodecyl sulphate (see Plate 2a).
Preparation ofcomponent CT
This could be prepared from component Cl by allowing activation to occur by adjusting the pH ofthe concentrated pool from the Sepharose 6B column to 7.4 without prior addition of Dip-F. Alternatively the Cl component from the Sepharose 6B column was adjusted to pH 7.4 suspension was incubated at 30°C for 15min. The suspension was cooled in ice, centrifuged, and the precipitate was washed twice with cold 0.1 M-NaCl. Component CT was eluted from the aggregates in 1 M-NaCI/5OmM-EDTA/50mM-Tris/HCl, pH5.5. All the subcomponents CTr and CTs and 80-90 % of the subcomponent Clq were eluted under these conditions and could be separated as described above for the unactivated subcomponents and appeared to be pure (see Plate 2b).
Preparation ofcomponent C4
Component C4 was separated from human serum by techniques developed from those of Schrieber & Miiller-Eberhard (1974) .
Preparation of rabbit anti-ovalbumin IgG and aggregates ofovalbumin-anti-ovalbumin Rabbit IgG was obtained by precipitation with 16% (w/v) Na2SO4 of rabbit anti-ovalbumin serum. The precipitate was resuspended and dialysed against 0.15M-NaCl. The solution was heated at 56°C for 1 h, and any precipitate formed was pelleted by centrifugation and discarded. The antibody content of the solution was estimated by precipitation with increasing concentrations of ovalbumin (Kabat & Mayer, 1961) , and the aggregate was prepared by the addition of the optimum concentration of ovalbumin at 2°C. The precipitate was washed twice with cold 0.9% NaCI, resuspended in NaCi at 10mg/ml, then Dip-F was added to 1 mm and the mixture stored at 2°C. It appeared to be stable for months.
Assays ofcomponents C1, C1q, CIr, Cls and C4 Haemolytic assays. Veronal/NaCl buffers were used as described by Nelson et al. (1966) . Haemolytic assays for components Cl, Clq, Clr, Cls and C4, and the cellular intermediates used in the titrations, were as described (Borsos & Rapp, 1963 Lepow et al., 1963; Nelson et al., 1966) . Results were expressed in H50 units, i.e. the dilution of test material giving 50% haemolysis of 1.5 x 108 sensitized erythrocytes.
Component CTs activity was measured by following the rate of inactivation of component C4 haemolytic activity (Gigli & Austen, 1969) . Component CTr activity was assayed by measuring the rate of conversion of component Cls into CTs form.
Extinction coefficient ofcomponents Clq, Clr and Cls
The values taken for calculation of weight ratios of components were Clq E280 0.68 (Reid et al., 1972) (Reid et al., 1972) and for components Clr, Cls, CTr and CTs 83 000 (Sim & Porter, 1976) .
Sodium dodecyl sulphate/polyacrylamide gel-electrophoresis
This was carried out as described by Fairbanks et al. (1971) . When reduction of the samples was necessary they were incubated with 50mM-dithiothreitol/4M-urea/1 % (w/v) sodium dodecyl sulphate/ 0.1 M-Tris/HCl, pH 8.0, at 37°C for 60min and then with 120mM-iodoacetamide for-a further 30min at the same temperature. Unreduced samples were incubated at 37°C for 60min in 20mM-iodoacetamide/4M-urea/1 % sodium dodecyl sulphate/0.1 MTris/HCI, pH 8.0. Coomassie Blue was used for staining protein (Weber & Osborne, 1969) .
Results

Preparation ofcomponent Cl
Repeated addition of Dip-F at all stages of the preparation ofcomponent Cl was essential to prevent spontaneous activation. lodoacetamide, to inactivate thiol-dependent enzymes, and phenanthroline, to inactivate the zinc-dependent tissue collagenase, were also added to the serum on dilution for euglobulin precipitation. The recovery of component C1 activity in the euglobulin precipitate ranged from 50 to 80%, with 10-20% remaining in the supernatant. The overall recovery from the Sepharose column was high, often up to 90 %, but the later active fractions were discarded (because a contaminant of apparent mol.wt. about l60000 was present), giving a final recovery of about 50 % overall. The recoveries of activity in one experiment are shown in Table 1 . When the material pooled from the Sepharosecolumn eluate was examined by electrophoresis in polyacrylamide gel in buffers containing sodium dodecyl sulphate, only subcomponents Clr, Cls and the two subunits of Clq were apparent (Plate la), but some material did not enter the gel. After reduction, the subcomponent Clr and Cls bands moved slightly more slowly and now had the same mobility, whereas component Clq gave the A, B and C chains and the contaminant was apparent moving a little ahead of the Clr and Cls bands (Plate 2b). The identification is apparent from the mobilities of the isolated subcomponent (Plate 2).
No activation of component Cl occurred during isolation, as judged by sensitivity of the haemolytic activity to inactivation by Dip-F nor by behaviour of the reduced complex on polyacrylamide-gel electrophoresis. After reduction, subcomponents CTr and CTs each separate into two components of lower If subcomponents Clr and Cls were mixed at equimolar ratio and increasing amounts were added to subcomponent Clq, maximum Cl haemolytic activity was reached at molar ratios of Clq/Clr or Clq/Cls of almost 1:4 (Fig. 2) (Fig. 3) . When Molar ratio of subcomponents CTr/Cls Fig. 3 . Activation of subcomponent Cls by Clr in solution as measured by development of the capacity to destroy the haemolytic activity ofcomponent C4 Subcomponent Cls was incubated with increasing ratios of subcomponents CTr or Cls for 60min at 37°C, in isoosmotic gelatine/veronal/NaCl buffer, pH7.4 (Nelson et al., 1966 
Activation of subcomponent Cls by antigen-antibody aggregates measured by destruction ofcomponent C4
When subcomponents Clq, Clr or Cls were each incubated alone with antibody-antigen aggregates no capacity to destroy the haemolytic activity of component C4 was generated. Similarly no inactivation of component C4 occurred in this assay in mixtures containing subcomponents Clq and Clr or Clr and Cls with the aggregates. However, in agreement with the haemolytic data, in the presence of aggregates and subcomponents Clq and Cls, component-C4-destructive capacity developed. This was approx. 20% of the activity developed when subcomponents Clq, Clr and Cls were mixed with aggregates at molar proportions Clq/Clr/Cls of 1:2:2. In both cases, however, activation of subcomponent Cls by antibody-antigen aggregates was followed by loss of the capacity to hydrolyse component C4 (Fig. 4) , presumably owing to continued proteolytic action. This finding may explain the variable activity of subcomponent Cis, whether measured by destruction of component C4 or by direct haemolytic activity, depending on the method of activation. If no inhibitors were added during the preparation, the subcomponent Cis was isolated Time (min) Fig. 4 . Activation of components Cl as measured by the development of capacity to destroy the haemolytic activity of component C4 when the subcomponents are mixed with antibody-antigen aggregates Antibody-antigen aggregates, prepared as described in the Materials and Methods section, were mixed with Clq at 1: 50 (w/w) ratio of Clq to antibody and incubated at 37°C for 30min in veronal/NaCl iso-osmotic buffer (pH7.4) (Nelson et al., 1966) , containing 5 mm-CaCl2. The aggregates were centrifuged and resuspended in the same buffer, and subcomponents CIr and Cls or Cls alone were added in molar ratio of Clr/Clq or Cls/Clq of 4:1. Samples were removed at different times, diluted 10000-fold and incubated with component C4 for 30min at 37°C in the gelatine/veronal buffers used for haemolytic assay. The component C4 remaining was assayed haemolytically. Subcomponents Clq+Clr+Cls, *; subcomponents Clq+Cls, A. fully activated and had the highest activity. If prepared unactivated, and then activated in solution by the addition of subcomponent Clr, or particularly by the addition of antibody-antigen aggregates to unactivated component Cl, the subcomponent CTs subsequently isolated showed a threefold range of specific activity (Table 4 ). The variability in activity of different preparations made by the same method of activation is presumably due to the simultaneous activation and destruction which made precise control difficult. Trace contamination of the subcomponents by other proteolytic enzymes may be another cause of variability.
Inactivation ofsubcomponents Clr and Cls by Dip-F When Dip-F was added to subcomponent CTr or Cls at different concentrations and their activity assayed by their capacity to activate subcomponent Cls or to destroy component C4, the percentage inhibitions were very similar (Table 5 ). In spite ofthe striking differences in specificity of these two enzymes, the reaction with Dip-F is apparently similar. Table 4 . Subcomponent CTs specific activities as measured by the destruction ofcomponent-C4 haemolytic activity In each assay there were 4000 haemolytic units of components C4 and 0.1 ug of subcomponent CTs per ml. After 30min incubation at 37°C, the C4 haemolytic activity remaining was assayed and the loss of activity gave a measure of the enzyme activity of subcomponent Cis. The results were expressed as a percentage of the enzyme activity ofthe most active preparation. Results are expressed as percentages of maximum activity. In agreement with previous work (summarized by Reid & Porter, 1975; Gigli & Austen, 1969) it has been found that the haemolytic activity ofcomponent C4 is destroyed readily by subcomponent Cls but not at all by subcomponent CTr, and hence the rate of loss of haemolytic activity of component C4 can be used as a measure of activation of subcomponent Cls or of whole Ci. Subcomponent Cls cannot be activated in solution by subcomponent Cls, but only by subcomponent CTr (contrary with the report by Morgan & Nair, 1975) , and in solution the presence of subcomponent Cl q has no influence on the rates of activation. When 5 mM-CaCI2 is Vol. 157 present the rate of activation of subcomponent Cls by subcomponent Clr decreases to 15% of that in the absence of Ca2 . Subcomponents Clr and Cls form a complex in the presence of Ca2+, and it is possible that this restricts the accessibility of the vulnerable peptide bonds in subcomponent Cls. The similarity in size and composition of subcomponents Cls and Clr (Sim & Porter, 1976) is further emphasized by their same susceptibility to inactivation by Dip-F (Table 5 ) and is in contrast with their marked difference in enzymic specificity.
It has been assumed that subcomponent Clr becomes auto-activatable owing to conformational changes after adsorption on antibody-antigen aggregates, probably through subcomponent Clq, and that this in turn activates subcomponent Cls. Yet we and others (Assimeh & Painter, 1975 ) find significant Cl haemolytic activity in mixtures of subcomponents Clq and Cls. No contamination by subcomponent Clr could be detected in either component, and, if the sensitized erythrocytes used for the haemolytic assay were prepared by using component C4 and subcomponent Cls rather than whole component Cl, no difference was found. Further evidence of the independent interaction of subcomponents Clq and Cls to generate component Ci haemolytic activity was given by assays with subcomponents Clq in the presence of increasing amounts of subcomponents Clr and Cls (Fig. 2) . The activity of subcomponents Clq and Cis was additive over that ofsubcomponents Clq+Clr+Cls. This suggests that subcomponent Cls may be activated by direct interaction with subcomponent Clq bound on to the sensitized erythrocytes, independently of activation through subcomponent Clr. The Cls/Clq molar ratio for optimum component Cl haemolytic activity was about 4:1 whether subcomponent Clr was present or not. Increasing the Clr/Cls ratio did not raise the haemolytic activity, suggesting that, when both are present together with Ca2 , subcomponents Clr and Cls are in an equimolar complex.
By using the destruction of component-C4 haemolytic activity as assay, it was found that, in the presence of subcomponent Clq bound to antibody-antigen aggregates, subcomponent Cis became activated, but again only to about 20% of the activity found if subcomponent Clr was also present. With increasing time the content of activated subcomponent-Cls fell in both cases, though rather faster when subcomponent Clr was also present. It is likely that this loss of activity with time is due to continued proteolysis of subcomponent CTs and that this must in part be due to autocatalytic destruction of subcomponent Cls. 
